Literature DB >> 9422909

Autotransfusion in major orthopaedic surgery: experience with 1785 patients.

B Borghi1, E Pignotti, M Montebugnoli, A Bassi, M Corbascio, N de Simone, K Elmar, U Righi, A M Laguardia, S Bugamelli, F Cataldi, R Ranocchi, M A Feoli, T Bombardini, G Gargioni, A G Franchini, G C Caroli.   

Abstract

Using a prospective audit, we have evaluated the efficacy of an integrated autotransfusion regimen which comprised predepositing and intra- and postoperative blood salvage in major orthopaedic surgery. We examined prospectively the records of 1785 patients (1198 females, 5867 males, mean age 62 (range 16-90) yr, preoperative haemoglobin concentration 13.4 (SD 1.4) g dl-1) undergoing total hip arthroplasty (THA, 1229 patients), THA after removal of internal fixation devices (RFD + THA, 18 patients), total knee arthroplasty (TKA, 263 patients), revision surgery of the hip (HR cup + stem revision, 197 patients; cup revision, 53 patients; stem revision, 16 patients) and total knee revision (TKR, nine patients). We estimated that the number of predonations (MSBOS = maximum surgery blood order schedule) was 2 u. for THA, TKA and TKR, and 3 u. for partial or total hip revision and total hip arthroplasty with fixation removal. We found that it was possible to obtain the MSBOS in 1597 patients (89.5%). Homologous red blood cell (HRBC) transfusions were carried out in 131 patients (7.3%). We found that the need to use HRBC was significantly associated with failure to meet the number of MSBOS, female sex, lower preoperative haemoglobin concentration, use of calcium heparin for antithrombosis prophylaxis, more extensive surgery, higher ASA rating and co-existing diseases such as coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9422909     DOI: 10.1093/bja/79.5.662

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

Review 1.  Blood management and patient specific transfusion options in total joint replacement surgery.

Authors:  J J Callaghan; A I Spitzer
Journal:  Iowa Orthop J       Date:  2000

2.  Reducing the risk of allogeneic blood transfusion.

Authors:  Battista Borghi; Hanna van Oven
Journal:  CMAJ       Date:  2002-02-05       Impact factor: 8.262

3.  Letter to the Editor: Combined Intravenous and Intraarticular Tranexamic Acid Does Not Offer Additional Benefit Compared with Intraarticular Use Alone in Bilateral TKA: A Randomized Controlled Trial.

Authors:  Xiang-Dong Wu; Di Wu; Yong Liu; Wei Huang
Journal:  Clin Orthop Relat Res       Date:  2020-04       Impact factor: 4.755

4.  Efficacy of a three-day prolonged-course of multiple-dose versus a single-dose of tranexamic acid in total hip and knee arthroplasty.

Authors:  Xiang-Dong Wu; Mian Tian; Yao He; Yu Chen; Yu-Zhang Tao; Long Shao; Changqi Luo; Peng-Cheng Xiao; Zheng-Lin Zhu; Jia-Cheng Liu; Wei Huang; Gui-Xing Qiu
Journal:  Ann Transl Med       Date:  2020-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.